Overall, the colorectal cancer story is encouraging

Endurance athletes and colorectal cancer risk

  • Many were surprised by the reported large risk increase for ultra-endurance runners; some reconsidered intense training.
  • Proposed mechanisms (all flagged as unproven): repeated gut ischemia during long efforts, NSAID overuse, high intake of simple-sugar gels/ultra-processed foods, microbiome disruption, low fiber, or some combination.
  • Some argued humans aren’t “built” for frequent ultra-distance efforts; others pushed back that this is speculative and not specific to CRC.
  • A linked study (via DOI) is cited as the source of the ultra-marathon data, but commenters stress it doesn’t yet explain causality.

Lifestyle, diet, and other possible contributors

  • Obesity, sugary drinks, and sedentary behavior are highlighted as 1.5–2x risk factors in younger adults; rising obesity/sedentary time may explain a large share of incidence increases.
  • Others suggest roles for microplastics, energy drinks, red/processed meat, and low fiber; debate surrounds how strong and causal these associations really are.
  • Some note ultra-endurance athletes often eat highly processed, high-sodium, low-fiber diets despite high activity levels.

Alcohol and generational trends

  • One commenter blames heavy millennial drinking; others counter with data that younger cohorts (especially Gen Z) drink less, or differently.
  • A cited meta-analysis suggests a J-shaped relationship: light/moderate drinking slightly lowers CRC risk, very heavy drinking increases it.

Screening age, access, and risks

  • Several younger commenters are interested in early colonoscopy but encounter resistance from physicians/insurers; some suggest exaggerating family history, others condemn this.
  • There’s disagreement over whether insurers or doctors are the main barrier; cost out-of-pocket ranges from “worth paying” to “completely out of reach.”
  • Anecdotes describe missed or delayed diagnoses in younger patients, sometimes despite colonoscopy.
  • Risks of colonoscopy (e.g., perforation, serious complications) are noted, especially in low-risk 30-somethings. Some advocate sticking to guideline ages; others accept extra tests as a personal tradeoff.
  • Discussion touches on stool tests, Shield/Cologuard, full-body MRIs, and the gap between cancer-specific vs overall-mortality benefits. An NEJM trial is cited where colonoscopy reduced CRC deaths but not all-cause mortality.

Interpreting rising rates in under-50s

  • One argument: better/earlier screening shifts diagnosed cases into younger age bins, inflating incidence there.
  • Others point out mortality in under-50s has also risen (though modestly), suggesting a real increase beyond detection artifacts.

UX and communication style

  • Many praise the clarity and impact of the data storytelling and science communication.
  • Others strongly dislike the click-through, JS-heavy, non-scrolling interface and broken back-button behavior, preferring a traditional article.